Topical Drug Delivery Market: Global Industry Research Report 2020-2027 | Envisage Research

Topical Drug Delivery Market - By Product (Semi-Solid Formulations, Solid Formulations, Liquid Formulations, Transdermal Products), By Route Of Administration (Dermal, Ophthalmic, Nasal, Or Mucosal, Rectal, And Vaginal), By Facility Of Use (Hospital Pharmacies, Homecare Settings, Burn Centres, Other Facilities), And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 183

Status: Published

Report Code: EMR100584

The topical drug delivery market is projected to reach USD 147 billion by 2027 from USD 95.2 billion in 2020, at a CAGR of 6.4 %. The high prevalence of skin & eye diseases, high incidence of burn injuries, and the growing prevalence of diabetes driving the demand for topical drug delivery. However, technical barriers related to skin irritation and permeability and drug failures and product recalls are the challenges associated with this market.



Topical drug delivery systems are designed to deliver drugs through topical routes such as the skin, mucosa or cavities in the body. These are applied locally for site specific action or to avoid first pass effect of the drug. Skin is the most readily accessible part of the body with a large surface area and is rich in blood vessels and porous structures, enhancing the absorption of the drugs. The topical drug delivery system has witnessed technological advancements over a period of time and is attracting many researchers to develop novel products in this area. Common skin diseases that are treated preferably by topical drug delivery system include bacterial infections, fungal infections, inflammations and pruritic manifestations, acne, psoriasis, hair and skin problems, and others. Nasal mucosa is highly perfused with blood vessels and has been proven as a site for faster absorption of drugs. Hence, there is increasing research toward the development of targeted drug delivery systems for nasal route. Topical is a highly preferred route of drug administration for the treatment of ocular disorders owing to its site-specific action, reduced first pass metabolism, and faster action.



The growing incidence and prevalence rate of tropical diseases is boosting the growth of the topical drug delivery systems market. According to the American Academy of Dermatology, in the U.S., about 50 million people are affected by acne each year. The global topical drug delivery systems market is expected to expand at a fast growth rate during the forecast period owing to factors such as increasing number of patients with skin diseases, preference for novel transdermal delivery systems, growing patient preference towards topical drugs over oral drugs owing to avoidance of bitter taste of the drugs taken orally, and desired site-specific actions to treat many disorders. However, high development cost, different solubility profiles of drugs making product formulation challenging, stringent regulatory requirements, and difficult testing procedure of final products are some of the factors restraining the growth of the global market.



Prominent players in the topical drug delivery market are Johnson & Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd (India), Crescita Therapeutics Inc. (Canada), and Mylan (US).



Janssen Global Services is a subsidiary of Johnson & Johnson. Janssen provides medicines for a wide array of health concerns in several therapeutic areas, including ADHD, general medicine, mental health, neurology, pain management, and women’s health. The company sells its products through a network of distributors across the US. It operates through three business segments, namely, Pharmaceutical, Consumer, and Medical Devices. It offers topical products through its pharmaceutical and consumer segments.



Analyst Commentary



The high prevalence of skin & eye diseases, high incidence of burn injuries, and the growing prevalence of diabetes driving the demand for topical drug delivery. However, technical barriers related to skin irritation and permeability and drug failures and product recalls are the challenges associated with this market.



On the basis of product, the semi-solid formulations segment is expected to account the largest market share of the market in 2020. The advantages of semi-solid formulations such as faster drug release and greater patient acceptability topical gels, wide applications of topical pastes for the treatment and prevention of skin irritation, high spread ability and washability of creams for the treatment of various skin types are the factors driving the growth of this market.



On the basis of route of administration, the dermal drug delivery segment accounted for the largest share of the market in 2018. This is mainly due to the high prevalence of skin diseases across the globe. For instance, the prevalence of psoriasis worldwide ranges between 0.09% and 11.43%, making it a serious global problem with at least 100 million individuals affected worldwide. (Source: WHO 2016).



On the basis of facility of use, Homecare settings accounted for the largest share of the market in 2018. Home care settings eliminate the need for patients to travel to healthcare facilities, thus saving time and money. Owing to this convenience and better affordability, an increasing number of patients are opting for home-based treatments, and these are some of the key factors driving the growth of this facility of use segment.



Segmentation



The global topical drug delivery systems market is segmented based on product, route of administration, Facility of use, and region. By product, the market is segmented into semi-solid formulations (creams, gels, ointments, pastes, and lotions), solid formulations (suppositories and powders), liquid formulations (solutions and suspensions), and transdermal products (transdermal patches and transdermal semi-solids). Based on route of administration, the global market is segmented into dermal, ophthalmic, nasal, or mucosal, rectal, and vaginal. In terms of Facility of use, the market is categorized into hospital pharmacies, Homecare Settings, Burn Centres, Other Facilities (academic & research institutes and diagnostic centres).



Regional Analysis



Geographically, the global topical drug delivery systems market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa North America dominated the market in 2018. Though, the North America region is expected to witness the highest CAGR during the forecast period. The rising prevalence of skin diseases, approvals, and launches of innovative topical formulations in the region, and funding for the development of topical drugs are some of the key factors driving the growth of this regional segment. For instance, in December 2018, Cipher Pharmaceuticals Inc. (Canada) received acceptance for its “A-101 40% topical solution” for review by Health Canada. This product is indicated for the treatment of raised seborrheic keratosis, which is a commonly occurring non-cancerous skin growth that affects more than 9 million Canadian adults. Similarly, in December 2018, GlaxoSmithKline (UK) invested USD 36.0 million in manufacturing sites in Canada to boost the production and support delivery of its leading topical pain reliever—VOLTAREN.



Europe is the second largest market due to growing geriatric population, increasing R&D investments, and rising adoption of novel drug delivery systems to treat chronic dermatological conditions. Asia Pacific is considered as an emerging market owing to higher prevalence of skin diseases due to unhealthy lifestyle among general population, and lack of hygiene, along with increasing awareness and accessibility for topical drugs for treatment of various diseases.



TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Form
2.3.1. Secondary Form
2.3.1.1. Preliminary data mining
2.3.2. Primary Form
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Nutraceuticals Ingredient Market
Chapter 5. Global Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
5.1. Global Nutraceuticals Ingredient Market Share, By Type, 2015 - 2027 (USD Billion)
5.1.1. Prebiotics
5.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. Amino Acids & Proteins
5.1.2.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.3. Omega-3 Fatty Acids
5.1.3.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.4. Others
5.1.4.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027(USD Billion)
6.1. Global Nutraceuticals Ingredient Market Share, By Application, 2015 - 2027 (USD Billion)
6.1.1. Food
6.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. Beverages
6.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.3. Animal nutrition
6.1.3.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.4. Others
6.1.4.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Nutraceuticals Ingredient Market Overview, By Form, 2015 - 2027(USD Billion)
7.1. Global Nutraceuticals Ingredient Market Share, By Form, 2015 - 2027 (USD Billion)
7.1.1. Liquid
7.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.2. Powder
7.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 8. Global Nutraceuticals Ingredient Market Overview, By Geography, 2015 - 2027(USD Billion)
8.1. Global Nutraceuticals Ingredient Market Share, By Geography, 2015 - 2027(USD Billion)
8.1.1. Market Type and projections, by Countries, 2015 - 2027 (USD Billion)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Nutraceuticals Ingredient Market Overview, By Countries, 2015 - 2027(USD Billion)
9.1. North America Nutraceuticals Ingredient Market Overview, 2015 - 2027 (USD Billion)
9.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.2. North America Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.3. North America Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
9.1.4. North America Nutraceuticals Ingredient Market Overview, By Form,2015 - 2027 (USD Billion)
9.1.5. North America Nutraceuticals Ingredient Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.5.1. U.S. Nutraceuticals Ingredient Market Overview, 2015 - 2027 (USD Billion)
9.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.5.1.2. U.S. Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.5.1.3. U.S. Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Nutraceuticals Ingredient Market Overview, 2015 - 2027 (USD Billion)
9.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.5.2.2. Canada Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.5.2.3. Canada Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Nutraceuticals Ingredient Market Overview, 2015 - 2027 (USD Billion)
9.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.5.3.2. Mexico Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.5.3.3. Mexico Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
9.1.5.3.4. Other Segment
Chapter 10. Europe Nutraceuticals Ingredient Market Overview, By Countries, 2015 - 2027(USD Billion)
10.1. Europe Nutraceuticals Ingredient Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.2. Europe Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
10.1.3. Europe Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
10.1.4. Europe Nutraceuticals Ingredient Market Overview, By Form,2015 - 2027 (USD Billion)
10.1.5. Europe Skin Care Types Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.5.1. Germany
10.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.1.2. Germany Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.1.3. Germany Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.2.2. France Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.2.3. France Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.3.2. UK Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.3.3. UK Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.4.2. Italy Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.4.3. Italy Nutraceuticals Ingredient Market Overview, By Application 2015 - 2027(USD Billion)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.5.2. Spain Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.5.3. Spain Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Type and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.6.3. Rest of Europe Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027(USD Billion)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Nutraceuticals Ingredient Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Asia Pacific Nutraceuticals Ingredient Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.2. Asia Pacific Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
11.1.3. Asia Pacific Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.4. Asia Pacific Nutraceuticals Ingredient Market Overview, By Form,2015 - 2027 (USD Billion)
11.1.5. Asia Pacific Nutraceuticals Ingredient Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.5.1. India
11.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.5.1.2. India Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.1.3. India Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Type and projections, 2015 - 2027(USD Billion)
11.1.5.2.2. China Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.2.3. China Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.5.3.2. Japan Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.3.3. Japan Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027(USD Billion)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Type and projections, 2015 - 2027(USD Billion)
11.1.5.4.2. South Korea Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.4.3. South Korea Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.5.5.2. Rest of Asia Pacific Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.5.3. Rest of Asia Pacific Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Nutraceuticals Ingredient Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. Middle East & Africa Nutraceuticals Ingredient Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.2. Middle East & Africa Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.3. Middle East & Africa Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.4. Middle East & Africa Nutraceuticals Ingredient Market Overview, By Form,2015 - 2027 (USD Billion)
12.1.5. Middle East & Africa Nutraceuticals Ingredient Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1.5.1. GCC
12.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.5.1.2. GCC Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.5.1.3. GCC Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.5.2.2. South Africa Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.5.2.3. South Africa Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.5.3.2. Rest of Middle East & Africa Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.5.3.3. Rest of Middle East & Africa Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.5.3.4. Other Segments
Chapter 13. South America Nutraceuticals Ingredient Market Overview, By Countries, 2015 - 2027 (USD Billion)
13.1. South America Nutraceuticals Ingredient Market Overview, 2015 - 2027 (USD Billion)
13.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.2. South America Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
13.1.3. South America Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
13.1.4. South America Nutraceuticals Ingredient Market Overview, By Form,2015 - 2027 (USD Billion)
13.1.5. South America Nutraceuticals Ingredient Market Overview, By Countries, 2015- 2026 (USD Billion)
13.1.6. Brazil
13.1.6.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.6.2. Brazil Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
13.1.6.3. Brazil Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.7.2. Argentina Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
13.1.7.3. Argentina Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Type and projections, 2015 – 2027
13.1.8.2. Rest of South America Nutraceuticals Ingredient Market Overview, By Type, 2015 - 2027 (USD Billion)
13.1.8.3. Rest of South America Nutraceuticals Ingredient Market Overview, By Application, 2015 - 2027 (USD Billion)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Type development
Chapter 15. Key Vendor Analysis
15.1. Kraft Heinz company
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Mice Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. GlaxoSmithKline
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Mice Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Amway
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Mice Benchmarking
15.3.4. Recent initiatives
15.4. Abbott
15.5. Kelloggs
15.6. Danone
15.7. CARGILL INC.
15.8. Nestle
15.9. Archer Daniels Midland
15.10. Aker Biomarine
Chapter 16. Nutraceuticals Ingredient Market Cost Analysis
16.1. Nutraceuticals Ingredient Market Key Type Analysis
16.1.1. Key Type
16.1.2. Price Trend of Key Type
16.1.3. Key Suppliers of Type
16.1.4. Market Concentration Rate of Type
16.1.5. Labor Cost
Chapter 17. Nutraceuticals Ingredient Chain, Sourcing Strategy and Downstream Buyers
17.1. Nutraceuticals Ingredient Market Chain Analysis
17.2. Upstream Type Sourcing
17.3. Type Form of Nutraceuticals Ingredient Market Major Manufacturers in 2020
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Type
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer 
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Nutraceuticals Ingredient Market share, by Type, 2020 & 2027 (%)
10. Global Nutraceuticals Ingredient Market share, by Prebiotics, by Type, 2015 - 2027 (USD Billion)
11. Global Nutraceuticals Ingredient Market share, by Amino Acids & Proteins, by Type, 2015 - 2027 (USD Billion)
12. Global Nutraceuticals Ingredient Market share, by Omega-3 Fatty Acids, by Type, 2015 - 2027 (USD Billion)
13. Global Nutraceuticals Ingredient Market share, by Others, by Type, 2015 - 2027 (USD Billion)
14. Global Nutraceuticals Ingredient Market share, by Application, 2020 & 2027 (%)
15. Global Nutraceuticals Ingredient Market share, by Food, by Application, 2015 - 2027 (USD Billion)
16. Global Nutraceuticals Ingredient Market share, by Beverages, by Application 2015 - 2027 (USD Billion)
17. Global Nutraceuticals Ingredient Market share, by Animal nutrition, by Application 2015 - 2027 (USD Billion)
18. Global Nutraceuticals Ingredient Market share, by Others, by Application 2015 - 2027 (USD Billion)
19. Global Nutraceuticals Ingredient Market share, by Form, 2020 & 2027 (%)
20. Global Nutraceuticals Ingredient Market share, by Liquid, by Form, 2015 - 2027 (USD Billion)
21. Global Nutraceuticals Ingredient Market share, by Powder, by Form 2015 - 2027 (USD Billion)
22. Global Nutraceuticals Ingredient Market share, by region, 2020 & 2027 (%)
23. Global Nutraceuticals Ingredient Market share, by region, 2015 - 2027(USD Billion)
24. North America Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
25. North America Nutraceuticals Ingredient Market share, by Countries, 2020 & 2027 (%)
26. U.S. Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
27. Canada Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
28. Europe Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
29. Europe Nutraceuticals Ingredient Market share, by Countries, 2020 & 2027 (%)
30. Spain Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
31. UK Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
32. Italy Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
33. Germany Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
34. France Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
35. Rest of Europe Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
36. Asia-Pacific Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
37. Asia-Pacific Nutraceuticals Ingredient Market share, by Countries, 2020 & 2027 (%)
38. China Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
39. India Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
40. Australia Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
41. Japan Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
42. Rest of Asia-Pacific Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
43. Middle East & Africa Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
44. Middle East & Africa Nutraceuticals Ingredient Market share, by Countries, 2020 & 2027 (%)
45. GCC Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
46. South Africa Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
47. Rest Of Middle East & Africa Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
48. South America Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
49. Brazil Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
50. Mexico Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
51. Argentina Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)
52. Rest Of South America Nutraceuticals Ingredient Market, 2015 - 2027(USD Billion)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Nutraceuticals Ingredient Market, 2015-2027 (USD Billion)
4. Nutraceuticals Ingredient requirement, by country, 2015-2027, (USD Billion)
5. North America Nutraceuticals Ingredient Market, by Type, 2015-2027 (USD Billion)
6. North America Nutraceuticals Ingredient Market, by Application, 2015-2027 (USD Billion)
7. North America Nutraceuticals Ingredient Market, by Form, 2015-2027 (USD Billion)
8. Europe Nutraceuticals Ingredient Market, by Type, 2015-2027 (USD Billion)
9. Europe Nutraceuticals Ingredient Market, by Application, 2015-2027 (USD Billion)
10. Europe Nutraceuticals Ingredient Market, by Form, 2015-2027 (USD Billion)
11. Asia Pacific Nutraceuticals Ingredient Market, by Type, 2015-2027 (USD Billion)
12. Asia Pacific Nutraceuticals Ingredient Market, by Application, 2015-2027 (Revenue, USD Billion)
13. Asia Pacific Nutraceuticals Ingredient Market, by Form, 2015-2027 (Revenue, USD Billion)
14. Middle East & Africa Nutraceuticals Ingredient Market, by Type, 2015-2027 (USD Billion)
15. Middle East & Africa Nutraceuticals Ingredient Market, by Application, 2015-2027 (USD Billion)
16. Middle East & Africa Nutraceuticals Ingredient Market, by Form, 2015-2027 (USD Billion)
17. South America Nutraceuticals Ingredient Market, by Type, 2015-2027 (USD Billion)
18. South America Nutraceuticals Ingredient Market, by Application, 2015-2027 (USD Billion)
19. South America Nutraceuticals Ingredient Market, by Form, 2015-2027 (USD Billion)
20. Global Nutraceuticals Ingredient Market, Company Market Share, 2020 - 2027 (%)
21. Kraft Heinz Company, : Type Benchmarking
22. Kraft Heinz Company, : Financial Performance
23. GlaxoSmithKline : Type Benchmarking
24. GlaxoSmithKline : Financial Performance
25. Amway : Type Benchmarking
26. Amway : Financial Performance
27. Abbott :Type Benchmarking
28. Abbott : Financial Performance
29. KELLOGG’S : Type Benchmarking
30. KELLOGG’S: Financial Performance
31. Danone, : Type Benchmarking
32. Danone, : Financial Performance
33. CARGILL INC., : Type Benchmarking
34. CARGILL INC., : Financial Performance
35. NESTLE, : Type Benchmarking
36. NESTLE, : Financial Performance
37. Archer Daniels Midland, : Type Benchmarking
38. Archer Daniels Midland, : Financial Performance
39. Aker Biomarine, : Type Benchmarking
40. Aker Biomarine, : Financial Performance

The Leading Key Players in Topical Drug Delivery Market

Johnson & Johnson (US)
Nestle SA (Switzerland)
Novartis AG (Switzerland)
GlaxoSmithKline (UK)
Bausch Health Companies (Canada)
Merck & Co (US)
Bayer AG (Germany)
Hisamitsu Pharmaceutical (Japan)
Glenmark Pharmaceuticals (India)
Cipla Ltd (India)
Crescita Therapeutics Inc. (Canada)
Mylan (US).